Skip to main content
OpenTrials
Completed

NCT Number: NCT00399230

A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye

To evaluate the effectiveness of NGT (Optive) vs. Systane Tears for patients with moderate to severe dry eye disease.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dry Eye Dry Eye Syndromes Eye Diseases Lacrimal Apparatus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Dr. Rajpal

McLean, Virginia, 22102, United States

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • · Dry eye disease diagnosis
  • Patients must currently be using Systane tears at least once a day and for at least 1 month.
  • Normal lid position and closure
  • Male or female of legal age of consent
  • Informed consent has been obtained
  • Likely to complete all required follow-up visits

Exclusion criteria

  • · Concurrent enrollment in an investigational drug or device study, or participation in such a study within 30 days of entry into this study.
  • Subject has a condition, or is in a situation which, in the investigator's opinion, may put the subject at a significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study.

Treatment and study plan

Optive

Drug

Sponsors and collaborators

Lead sponsor

Innovative Medical

Industry

Registry information

Important dates

First posted
Nov 14, 2006
Registry last updated
Aug 21, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.